Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$843K Sell
15,800
-34,270
-68% -$1.72M 1.27% 27
2017
Q2
$2.43M Sell
50,070
-110,900
-69% -$5.02M 4.19% 5
2017
Q1
$7.15M Buy
160,970
+13,000
+9% +$562K 9.41% 1
2016
Q4
$5.68M Sell
147,970
-3,665
-2% -$145K 6.53% 2
2016
Q3
$6.41M Buy
151,635
+24,383
+19% +$1.04M 5.08% 2
2016
Q2
$5M Sell
127,252
-8,048
-6% -$320K 4.3% 4
2016
Q1
$5.66M Buy
135,300
+13,000
+11% +$515K 5.93% 3
2015
Q4
$5.49M Buy
+122,300
New +$5.4M 4.05% 5

Other funds holding ABT

FT Options's ABT Position: Q3 2017 in Review

FT Options reduced its Abbott (ABT) stake by 68% in Q3 2017, selling an estimated $1.72M and leaving 15,800 shares worth $843K. The position accounts for 1.27% of the portfolio, ranked #27.

FT Options first reported a position in ABT in Q4 2015 and has held it in 8 quarters since. The position peaked at $7.15M in Q1 2017. 1,597 funds tracked by Wall St. Rank hold ABT as of Q3 2017.

  • FT Options held 15,800 shares of Abbott worth $843K as of Q3 2017.
  • FT Options sold 34,270 Abbott shares in Q3 2017, an estimated $1.72M.
  • Abbott made up 1.27% of FT Options's portfolio in Q3 2017, its #27 holding.
  • FT Options first reported a position in Abbott in Q4 2015 and has held it in 8 quarters since.
  • FT Options's Abbott position peaked at $7.15M in Q1 2017.
  • 1,597 funds tracked by Wall St. Rank held Abbott as of Q3 2017.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.